Animal Health Institute member companies invested $747 million in 2012 on the discovery and development of new medicines for animals and the maintenance of existing products. That figure is a 4.6 percent increase over the previous year, according to AHI’s latest Research and Development Survey.
“Innovation is essential to keeping a pipeline of new products that are needed by veterinarians, livestock producers and pet owners to keep animals healthy,” said AHI President and CEO Alexander S. Mathews. “This level of investment by our members demonstrates their commitment to innovation and to a steady supply of safe and effective medicines.”
Data were collected and compiled by the Animal Health Institute. R&D spending is calculated according to the type of product manufactured by AHI’s member firms: pharmaceuticals, biologics, feed additives, insecticides and diagnostics.
A compilation of surveys from the past three years showing trends in animal health products sales and research and development expenditures is available from AHI. The report includes combined sales figures of AHI members for ruminant, swine, poultry, small animals, and equine products.
Sales totals for these species are broken down as feed additives, biologics and insecticides, and pharmaceuticals. No further breakdown or tabulations are provided, although the report does track trends for the reported categories for 2010, 2011, and 2012. The report is $150 USD: copies can be ordered by contacting Marie Gilmore at the Animal Health Institute, email@example.com or (202) 637-2440.